Dallah Healthcare Holding Co.’s second-quarter net profit (SAR 35.9 million) was 21 percent lower than Saudi Fransi Capital’s estimate and 13 percent below a consensus forecast, the brokerage firm said in a report.
The investment arm of Banque Saudi Fransi maintained a “hold” rating on the stock and reduced its target price to SAR 140 from SAR 145.
The launch of operations at Dallah’s children’s hospital in Riyadh and outpatient clinics may support the stock’s performance in the medium term, the report added.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}